Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Russell B. Egerdie"'
Autor:
Karl R. Westenfelder, Scott Montgomery, Yair Lotan, Donna Mayne, Joseph Zadra, Godfrey K. Jansz, Scott Campbell, Eric W. Klein, Safedin Beqaj, Richard Harris, Ellen Wallace, Timothy A. Richardson, Bernard Goldfarb, Michael B. Williams, Alon Z. Weizer, Julia A. Bridge, Andrew M. Hiar, Kevin Cline, Xixi Lu, John Danella, Russell B. Egerdie, Timothy J. Bradford, Iris M. Simon, Franciscus Johannes P. van Valenberg, Andrew F. Trainer, J. Alfred Witjes, Fred Wolk, Michael Bates, Wade J. Sexton, Arnulf Stenzl, Russell Higuchi, Richard D. David
Publikováno v:
European Urology Oncology, 4, 1, pp. 93-101
European Urology Oncology, 4, 93-101
European Urology Oncology, 4, 93-101
Contains fulltext : 245130.pdf (Publisher’s version ) (Open Access) BACKGROUND: In patients with haematuria, a fast, noninvasive test with high sensitivity (SN) and negative predictive value (NPV), which is able to detect or exclude bladder cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901715197fe47d19ae21bff2290f55e8
https://doi.org/10.1016/j.euo.2020.09.001
https://doi.org/10.1016/j.euo.2020.09.001
Autor:
Andrew M. Hiar, Michael Bates, Richard Harris, Kevin Cline, Iris M. Simon, Julia A. Bridge, Yair Lotan, F Johannes P van Valenberg, Alon Z. Weizer, Russell B. Egerdie, Brian Rhees, Eric W. Klein, Safedin Beqaj, Donna Mayne, Bernard Goldfarb, Andrew F. Trainer, J. Alfred Witjes, Ellen Wallace, Fred Wolk, Arnulf Stenzl, Timothy J. Bradford, Joseph Zadra, Suling Zhao, Michael B. Williams, Godfrey K. Jansz, Karl R. Westenfelder, Richard D. David, Timothy A. Richardson, Wade J. Sexton, Russell Higuchi, Scott Campbell, Barry Shepard, John Danella, Sijian Ge, Scott Montgomery
Publikováno v:
European Urology, 75, 853-860
European Urology, 75, 5, pp. 853-860
European Urology, 75, 5, pp. 853-860
Background A fast, noninvasive test with high sensitivity (SN) and a negative predictive value (NPV), which is able to detect recurrences in bladder cancer (BC) patients, is needed. A newly developed urine assay, Xpert Bladder Cancer Monitor (Xpert),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3201942008d977ce653d5a31275c79
https://doi.org/10.1016/j.eururo.2018.11.055
https://doi.org/10.1016/j.eururo.2018.11.055
Autor:
David Sussman, Heinrich Schulte-Baukloh, Russell B Egerdie, Karel Everaert, Kristin Khalaf, Jennifer Gruenenfelder, Manher Joshi, Quanhong Ni
Publikováno v:
INTERNATIONAL JOURNAL OF UROLOGY
Objective To evaluate the impact of onabotulinumtoxinA on individual domains of the quality of life questionnaires in a pooled analysis of two phase 3 trials in overactive bladder patients with urinary incontinence who were inadequately managed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da80494ebfa10df3bee712eda7e9f8f0
https://pubmed.ncbi.nlm.nih.gov/26391359
https://pubmed.ncbi.nlm.nih.gov/26391359